Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
10.62
-0.25 (-2.30%)
At close: May 18, 2026, 4:00 PM EDT
10.60
-0.02 (-0.19%)
Pre-market: May 19, 2026, 5:44 AM EDT
Immatics Market Cap
Immatics has a market cap or net worth of $1.42 billion as of May 19, 2026. Its market cap has increased by 133.86% in one year.
Market Cap
1.42B
Enterprise Value
918.53M
1-Year Change
133.86%
Ranking
Category
Stock Price
$10.62
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.42B, an increase of 725.57%. That is a compound annual growth rate of 32.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 1.46B | 3.55% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.53B |
| Nuvation Bio | 1.50B |
| Novavax | 1.49B |
| Damora Therapeutics | 1.48B |
| Vir Biotechnology | 1.48B |
| AtaiBeckley | 1.47B |
| GH Research | 1.47B |
| Immunocore Holdings | 1.43B |